GN-HEARING
3.5.2021 09:02:09 CEST | Business Wire | Press release
GN Hearing, the global leader in hearing aid innovation, today unveils Interton Move , the newest addition to its leading portfolio of hearing solutions that caters to all user needs. Interton Move makes great sound quality and best-in-class connectivity more accessible, helping hearing care professionals meet the diverse needs of people living with hearing loss.
The lineup of 10 essential hearing aids represents the biggest upgrade in the history of Interton. People from across the hearing loss spectrum can now get more out of life with greater choice than ever before. Most importantly, people can now feel confident when communicating with friends and family as they can focus on what they want to hear. They benefit from improved listening comfort in different environments, made possible thanks to a new, faster, more powerful sound processing platform. The launch also presents new rechargeability options and full smartphone support with direct audio streaming and an app for personalization. These vital elements result in high-quality, yet affordable hearing care with all the benefits of GN’s leading and proven technology.
Globally, 430 million people live with hearing loss and only 1 in 5 people who could benefit from hearing aids actually use them.1 Untreated hearing loss has wide-reaching impacts on a person’s quality of life and happiness. As hearing loss can be perceived by some as a small problem and something to ignore or put up with, hearing aids may be seen as an overwhelming solution. With the new Interton Move portfolio, hearing care professionals can now offer simple and straightforward hearing care to more people than ever before.
GN Hearing CEO and President, Gitte Aabo, explains: “At GN Hearing, we want to make life sound better for every person with hearing loss. Treating hearing loss can radically transform an individual’s life, as they can hear more and return to doing what they love. With the launch of Interton Move, we’re pleased to support the crucial role that hearing care professionals play in helping people access the hearing care they need.”
The extensive portfolio includes a mini rechargeable Receiver-in-Ear (RIE), a mini Behind-the-Ear (BTE), custom hearing aids, and even a ‘Super Power’ option for profound hearing loss. The rechargeable RIE model and its matching desktop charger provide freedom from batteries and up to 30 hours of use on a single charge.
All Interton Move users can enjoy high-quality streaming of calls, music, and other audio directly from compatible Apple and AndroidTM devices. Meanwhile, the Interton Sound smartphone app enables users to personalize their hearing experience and connect to GN’s extensive range of wireless accessories.
All aspects of the fitting and onboarding process have been upgraded to improve the user experience and to ensure that the start of a person’s hearing journey is as seamless as possible. To make consulting easier for hearing care professionals, the Interton Fitting Software follows the same workflow as all other GN Hearing solutions.
Interton Move will roll out globally and be available in the first countries from May 2021.
NOTES TO EDITORS
About Interton
Interton was founded in Germany in 1962 and is part of the GN Group. Interton hearing aids are designed in Denmark and powered by pioneering technology that has transformed the sound quality, functionality, and comfort of hearing aids.
Visit our homepage interton.com – and connect with us on Facebook.
About GN Group
The GN Group enables people to Hear More, Do More and Be More through its intelligent hearing, audio and video collaboration solutions. Inspired by people and driven by our innovation leadership, we leverage technological synergies between our hearing and audio divisions to deliver unique and increasingly individualized user experiences in our products and solutions.
150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound and video processing, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra, BlueParrott and FalCom in 100 countries. Founded in 1869, the GN Group employs 6,500 people and is listed on Nasdaq Copenhagen (GN.CO).
Visit our homepage GN.com and connect with us on LinkedIn and Facebook .
© 2021 GN Hearing A/S. All rights reserved. Interton is a trademark of GN Hearing A/S. Apple, the Apple logo, iPhone, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google LLC.
1 WHO: Deafness and hearing loss: https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss . Accessed on April 12, 2021. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005229/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network15.7.2026 22:00:00 CEST | Press release
Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan's Evercode WT services Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider (CSP) Program. The partnership broadens access to high-quality, scalable single cell sequencing across Australia, the wider Asia-Pacific region, and beyond. Garvan is one of Australia's preeminent medical research institutions, with the Genomics Platform having deep experience in cell sorting, capture, and sequencing. As a Certified Service Provider, Garvan will offer Parse's Evercode WT kits to researchers across the region. "We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Ins
Grafana Labs Named a Leader in 2026 Gartner® Magic Quadrant™ for Observability Platforms and Positioned Furthest in Completeness of Vision15.7.2026 20:21:00 CEST | Press release
Named a Leader for the third consecutive year and placed furthest in vision for the second year in a row, the company has had a landmark year of innovation as observability becomes essential infrastructure for teams building and running AI at scale. Grafana Labs, the company behind the open observability cloud, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Observability Platforms for the third consecutive year, and positioned furthest on the Completeness of Vision axis for the second year running. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715814984/en/ 2026 Gartner® Magic Quadrant™ for Observability Platforms We believe this placement reflects where the market is headed: toward open, composable observability that helps teams in the AI era understand systems that are increasingly complex and agentic, and rapidly scaling thanks to AI-assisted engineering. A Platform Built for the AI Era
Spectro Cloud Raises $100 Million Series D to Help Customers Move AI Infrastructure Into Production Across Enterprise, Public Sector, Neocloud and Sovereign Cloud Environments15.7.2026 18:20:00 CEST | Press release
Growth Equity at Goldman Sachs Alternatives leads oversubscribed round with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus as organizations look to turn AI silicon into business outcomes Spectro Cloud, a leading provider of AI infrastructure management software, today announced it has raised more than $100 million in an oversubscribed Series D funding round led by Growth Equity at Goldman Sachs Alternatives, with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus. The new funding brings Spectro Cloud’s total capital raised to $260 million and will accelerate the company’s mission to help enterprises, public sector organizations, neoclouds and sovereign clouds build and operate production AI infrastructure with greater control over cost, security and governance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715551858/en/ Spectro Cloud raises $
K-Beauty Goes Global: Sales Surge 53% as Korean Innovation Reshapes Beauty Growth15.7.2026 16:00:00 CEST | Press release
New NIQ data shows K-Beauty value sales rose 53% year-over-year and 131% over two years, underscoring how regional beauty trends, social commerce and ingredient-led innovation are reshaping global beauty growth. NIQ (NYSE: NIQ), a global leader in consumer intelligence, today released new findings showing K-Beauty has become a rapidly growing global beauty segment, with value sales up 53% year-over-year and 131% over the past two years. The data points to a broader shift in beauty growth, as regional innovation, social commerce and digitally driven consumer demand increasingly shape what scales globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715867578/en/ K-Beauty accelerates across global markets In its latest report, K-Beauty Goes Global, NIQ shows how Korean beauty is reshaping consumer expectations, accelerating innovation cycles and redefining competitive dynamics across the global beauty market. What began
Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage15.7.2026 15:00:00 CEST | Press release
Viz Neuro™ Suite, including Viz ICH™ and Viz ICH Plus™, to facilitate rapid detection and care coordination for patients with basal ganglia hemorrhage across trial sites nationwide. Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to potentially improve functional patient outcomes. The study aims to initiate both randomization and surgical intervention within 120 minutes of key clinical time points, reflecting the urgent nature of intracerebral hemorrhage care. Participating sites will have the ability to leverage the Viz Neuro Suite platform, including Viz ICH and Viz ICH Plus, to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom